Six leading public health organizations today asked federal courts to allow them to intervene in two lawsuits brought by the electronic cigarette and cigar industries against the Food and Drug Administration’s 2016 rule establishing public health oversight of e-cigarettes, cigars and other previously unregulated tobacco products
TRENTON, NJ – July 21, 2017 – Governor Chris Christie has signed into law a measure that prohibits the sale of tobacco products, including electronic smoking devices to anyone under 21. The current age requirement is 19.
The House Labor, Health and Human Services and Education Committee marked up its FY 2018 spending bill today including a $1.1 billion funding increase for the National Institutes of Health (NIH) and a $82 million funding boost for the National Cancer Institute (NCI).
Unlike the House version of this bill, senators did not exempt from FDA oversight many cigars, including some cheap and flavored cigars often popular with youth. The Committee’s action preserves FDA authority to regulate all tobacco products as granted by Congress
AUGUSTA - The American Cancer Society Cancer Action Network (ACS CAN) applauds the Maine legislature for their overwhelming bipartisan support of LD1170. The legislation raises the age of sale for tobacco products, including electronic smoking devices, from 18 to 21.
Any attempt to repeal the ACA without replacing it with equal or better coverage will leave our health care system in shambles. If the existing law is abolished, 32 million Americans could lose their insurance coverage in the next decade. This approach is completely unacceptable for the patients we represent.
The Maryland Save Your Skin Coalition applauds Prince George’s County Council for passage earlier today of a local ordinance prohibiting minors from using indoor tanning devices in the county.
Sacramento, CA – The voices of cancer patients, survivors and their loved ones are making a difference at the Capitol as evidenced by the critically-important cancer-fighting policies that passed the Legislature in 2016.
This bill would leave patients and those with pre-existing conditions paying more for less coverage and would substantially erode the progress our nation has been trying to make in providing affordable, adequate and meaningful coverage to all Americans.
The U.S. House Appropriations Committee approved a bill today that would greatly weaken the Food and Drug Administration’s (FDA) oversight of tobacco products. The provision was included in the FY 2018 Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies appropriations bill.